Gland Pharma Limited has informed the Exchange regarding Change in Director(s) of the company.
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gland Pharma has announced the reappointment of Ms. Naina Lal Kidwai as an Independent Director for a second consecutive term of five years, effective May 17, 2026. The appointment was approved by shareholders through postal ballot e-voting. Ms. Kidwai, who has been on the board since 2021, brings extensive experience including her roles as Chairman of Rothschild & Co India, Senior Advisor at Advent Private Equity and TPG Rise Climate, and past positions at HSBC India and Nestle. She also serves on the boards of Holcim, UPL, and Biocon. Her reappointment comes with approved commission on profits as remuneration.
This is a routine governance announcement confirming continuity of an experienced board member. The reappointment with shareholder approval demonstrates stable corporate governance with no negative implications for shareholders.